McKinsey’s latest benchmarking data highlights that those judged to be ‘leaders’ in procurement, have 40% higher maturity when compared to those in the middle of the pack.
![](https://pharmasource.global/wp-content/uploads/2024/07/Mckinsey-graph-1024x591.jpg)
The analysis suggests that companies with top-quartile procurement maturity have EBITDA margins at least five percentage points higher than their less mature peers.
“The best procurement organizations understand that success in today’s complex and fast-moving environment requires mastery of data-driven decision-making. They have invested in the digital infrastructure and analytical tools and capabilities needed to achieve this goal.”
Access the full report here